| Title |
The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, December 2011
|
| DOI | 10.1158/1535-7163.mct-11-0415 |
| Pubmed ID | |
| Authors |
Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott L. Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel D. Leverson, Chris Tse, Steven W. Elmore |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 120 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 33 | 27% |
| Researcher | 13 | 11% |
| Student > Master | 11 | 9% |
| Student > Bachelor | 9 | 7% |
| Student > Doctoral Student | 6 | 5% |
| Other | 19 | 15% |
| Unknown | 32 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 28 | 23% |
| Agricultural and Biological Sciences | 24 | 20% |
| Medicine and Dentistry | 11 | 9% |
| Chemistry | 9 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
| Other | 11 | 9% |
| Unknown | 32 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2023.
All research outputs
#2,531,538
of 25,837,817 outputs
Outputs from Molecular Cancer Therapeutics
#301
of 4,105 outputs
Outputs of similar age
#17,772
of 250,534 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#4
of 62 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,534 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.